| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Chronic myeloid leukemia | 107 | 16 | |
| Gastrointestinal stromal tumors | 30 | 5 | |
| Acute lymphocytic leukemia | 5 | 0 | |
| Dermatofibrosarcoma protuberans | 3 | 0 | |
| Mast cell activation syndrome | 2 | 1 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Diarrhea | 6 | |
| Nausea | 3 | |
| Elevated liver enzymes | 2 | |
| Fatigue | 2 | |
| Fluid retention (edema) | 2 | |
| Rashes (redness, swelling) | 2 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 3 | |
| Moderate | 6 | |
| Mild | 12 | |
| None | 2 |